Home | Business News | Browse by Publication | B | Business Wire

Cell Signaling Technology, Inc. Expands its Patent Portfolio on Motif-Specific Antibodies.

Publication: Business Wire
Publication Date: 01-MAR-06
Format: Online
Delivery: Immediate Online Access

Article Excerpt
BEVERLY, Mass. -- Cell Signaling Technology, Inc. (CST) announced today that it has been issued a second U.S. Patent (No. 6,982,318) covering a novel and powerful class of motif-specific and context-independent antibodies, and has received a notice of allowance in a third U.S. application directed to the same technology....

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Business Wire
Rogers Corporation to Present at 27th Annual Institutional Investors C..., March 01, 2006
Paramount Energy Trust Advises on 2005 U.S. Income Tax Reporting., March 01, 2006
Maguire Properties' Board of Directors Votes to Terminate Option Prope..., March 01, 2006
Brightpoint Announces that John J. Ludwig Rejoins Brightpoint as Senio..., March 01, 2006
Vertis Customer Focus(R) Study Reveals Furniture Purchasing Trends; Fu..., March 01, 2006

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.